Market Tracker

11/21 6:05pm ET

Hyperion Therapeutics Inc (NASDAQ:HPTX)

20.67
Data as of Nov 21
 -0.15 / -0.72%
Today’s Change
19.45
Today|||52-Week Range
32.98
+2.23%
Year-to-Date

Today’s Trading

Previous close20.82
Today’s open21.06
Day’s range20.63 - 21.29
Volume99,654
Average volume (3 months)154,350
Market cap$428.3M
Dividend yield--
Data as of 4:00pm ET, 11/21/2014

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-213.54%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales9.30
Price/Book3.48

Competitors

 Today’s
change
Today’s
% change
CHRSCoherus Biosciences ...+0.05+0.38%
RNAProsensa Holding NV-0.07-0.61%
OSIROsiris Therapeutics ...+0.06+0.46%
PACBPacific Biosciences ...+0.03+0.44%
Data as of 4:00pm ET, 11/21/2014

Financials

Next reporting dateFebruary 26, 2015
EPS forecast (this quarter)-$0.22
Annual revenue (last year)$42.2M
Annual profit (last year)$16.6M
Net profit margin39.40%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Donald J. Santel
Chief Financial Officer &
Senior Vice President
Jeffrey S. Farrow
Corporate headquarters
Brisbane, California

Forecasts